US12426885B2 - Mesh cap for ameliorating outpouchings - Google Patents
Mesh cap for ameliorating outpouchingsInfo
- Publication number
- US12426885B2 US12426885B2 US17/020,797 US202017020797A US12426885B2 US 12426885 B2 US12426885 B2 US 12426885B2 US 202017020797 A US202017020797 A US 202017020797A US 12426885 B2 US12426885 B2 US 12426885B2
- Authority
- US
- United States
- Prior art keywords
- outpouching
- medical apparatus
- endovascular
- retention arm
- mesh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12031—Type of occlusion complete occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12177—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure comprising additional materials, e.g. thrombogenic, having filaments, having fibers or being coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/1219—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/145—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/145—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/146—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/1215—Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/12186—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices liquid materials adapted to be injected
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00017—Electrical control of surgical instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00818—Treatment of the gastro-intestinal system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00898—Material properties expandable upon contact with fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
- A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
- A61B2017/12068—Details concerning the detachment of the occluding device from the introduction device detachable by heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
- A61B2017/22068—Centering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3966—Radiopaque markers visible in an X-ray image
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
Definitions
- the described disclosure relates generally to endovascular devices, and, more particularly, relates to a specifically shaped support cap atop a mesh disc.
- the present disclosure is applicable to both gastrointestinal (GI) organs, vascular aneurysms and brain aneurysms. More specifically, the present disclosure is applicable in the repair of outpouchings, including both diverticulum and aneurysms.
- the present disclosure relates to an endovascular device for filling of a variety of vascular malformations, or other pathologic outpouchings.
- Outpouchings may include vascular aneurysms found in intracranial aneurysms, a fusiform aneurysm which is an outpouching of the arterial wall and a saccular aneurysm, which consists of a neck, a stem, and a dome.
- Additional current procedures also incorporate the use of a stent, for example, an intercranial stent, to function as a buttress to retain the coils within the aneurysmal sac, particularly in outpouchings or aneurysms exhibiting wide-necked anatomies.
- a stent for example, an intercranial stent
- This approach may increase the potential of damage to surrounding blood vessels, and/or require antiplatelet therapy to prevent in-stent thrombosis which increases the potential for bleeding complications.
- the present disclosure employs a surgical device including a mesh element, positioned predominantly across the neck of the aneurysm/out-pouching to overcome this limitation.
- the prior art also discloses the use of hydrogel and/or hydrogel combined, particularly, in a vascular environment.
- the use of hydrogel in some instances may exacerbate medical difficulties due to uneven swelling of the hydrogel, adversely altering the delivery characteristics for the related mesh occluders and otherwise presenting difficulties for use in certain treatments.
- the present disclosure obviates the short comings of the prior art with the utilization of a mesh or occluding element, and associated components, that secure the position of the occluding element relative to an outpouching before detachment, and before and/or subsequent to placement of additional embolic materials including embolic coils. More specifically, the present disclosure comprises a self-expandable occluding device which can both cover the neck of the outpouching and serve as a permanent embolic plug thereby immediately stabilizing the outpouching.
- the self-expandable device effectively covers the neck of an outpouching with, for example, a mesh, or other at least partially occluding component, in a desired orientation across the neck of the outpouching without projecting into the parent vessel.
- the device incorporates elements which immediately stabilize the device in the outpouching, in effect, functioning as a permanent embolic plug.
- the present disclosure combines an embolic disc with retention arms of flexible material, such as wire comprised of, for example, shape memory material including metals and polymers, super-elastic materials, spring material, etc. which deploy within the outpouching and provide immediate stabilization thereby retaining the occluding component or mesh across the neck of the outpouching.
- the arms are in the form of coils are configured to deploy into three dimensional structures.
- the retention arms may be in the shape of a coil defining a structure which at least partially follows the contours of the inner area of the outpouching to stabilize, for example, immediately stabilize, the occluding disc or mesh adjacent the neck of the outpouching.
- the retention arms in the form of a coil or other configuration may be configured to engage or “grip” the inner wall of the outpouching, with the mesh or occluding element optimally positioned at the neck of the outpouching.
- the configuration of the retention arms may be in the form of one or more coil loops connected together to form a dome-shape structure or alternatively may be independent from each other.
- the retention arms may not necessarily form a coil-shape upon deployment but may be slightly curved orientation or even relative linear in orientation.
- the one or more retention arms may inter-engage with one or more primary embolic coils, previously or subsequently introduced within the outpouching, to provide a further stabilizing or retaining structure within the outpouching.
- the retention arms may engage with hydrogel injected within the outpouching or aneurysm, and cooperate with the hydrogel, to provide further supportive functions.
- the present disclosure provides a mesh occluder for treatment of an outpouching, and a system and method for deploying the mesh occluder from a parent vessel into the outpouching.
- the system includes an occluding component, for example, in the form of a mesh, that can at least partially or fully cover the neck of an outpouching.
- the mesh occluder establishes a permanent embolic plug in the outpouching.
- the mesh occluder may include one or more self-expanding components which provide a simple or unified complex matrix that expands as it is deployed and achieves multiple configurations including, and without limitation, a generally half-spherical or semi-ovoid configuration, or other shapes such as pyramidal, kidney-shaped, bi-lobed, or other complex shapes, so that the self-expandable outpouching-filling device can be secured promptly in its desired position within the outpouching.
- the filling device includes retention arms which are slightly curved and/or linear,
- the optional configuration of the occluding component for example, a mesh disc, of the mesh occluder of the present disclosure may have a single layer, or be multi-layered.
- Other, optional embodiments of the occluding component or mesh disc include an opening through the occluding component, for example, generally centrally located, to permit introduction of an embolic material such as a hydrogel, gelfoam, ethanol, polyvinyl-alcohol particles, calibrated microspheres, central vascular plugs, coils, n-butyl-cyanoacrylate glue, fibrin glue, polidocanol-foam, alcoholic prolamin solution, and ethylene vinyl alcohol copolymer.
- an embolic material such as a hydrogel, gelfoam, ethanol, polyvinyl-alcohol particles, calibrated microspheres, central vascular plugs, coils, n-butyl-cyanoacrylate glue, fibrin glue, polidocanol-foam,
- the areas of the occluding element defining the opening may have its edges tapered or dimpled inward relative to the outpouching, to define a cone-like region to facilitate entry or re-entry of components, embolic fluid, etc. into the outpouching.
- the mesh occluder may be a component of a medical system including a microcatheter and a delivery wire to which the mesh occluder is attached.
- the mesh occluder may be detachably connected to the delivery wire.
- the distal end of the microcatheter can extend through the occluding component, for example, through the opening in the occluding component thereby providing a conduit to deliver primary and/or supplemental embolic materials into the outpouching.
- the embolic materials may include coils, liquid embolic, hydrogel, combination devices, and other embolic materials known in the art. These may most often be deployed serially to fill the contours of an outpouching.
- an outpouching is a vascular aneurysm.
- the present disclosure provides a mesh occluder for an outpouching or aneurysm in a vessel or an intestine which may be at least partially self-expandable and capable of immediate stabilization within moments of deployment.
- the rate of deployment of the retention arms from a compressed state within the microcatheter to an expanded state within the outpouching is controlled to be slower than the rate of expansion of the occluding or mesh element. This may allow more precise positioning of the occluding element or disc across the outpouching's neck, while avoiding the potential trauma of the retention arms being dragged across the internal walls of the outpouching.
- the present disclosure includes a self-expandable outpouching filling device having a compressed undeployed configuration and an expanded three-dimensional deployed configuration, a delivery member (such as a wire or hypotube/microcatheter), and a severable deployment system including a junction capable of releasing the self-expandable outpouching filling device.
- the outpouching filling element of the present disclosure in the preferred embodiment, is constructed of a metal such as platinum or platinum alloys, nitinol, and/or other biocompatible metals.
- the severable deployment element may be mechanically, electrolytically, or thermally, hydrostatically, chemically, or otherwise severed to separate the self-expandable outpouching filling device from the delivery member.
- FIG. 1 illustrates the medical system including a handle or control element, a microcatheter extending from the handle, a delivery component at least partially disposed within the microcatheter and an occluding component of the mesh occluder at the distal end of the delivery component in accordance with the principles of the present disclosure
- FIG. 2 is a side elevation view illustrating the microcatheter of the medical system accessing, through a vessel, an outpouching, and with the mesh occluder deployed relative to the outpouching with the occluding element at least partially spanning the neck of the outpouching and the retention arms in the form of one or more coils deployed within the interior of the outpouching in accordance with the principles of the present disclosure;
- FIG. 3 is a side elevation view similar to the view of FIG. 2 illustrating a control element of the medical system delivering an embolic coil within the outpouching in accordance with the principles of the present disclosure
- FIG. 3 A is a side elevation view similar to the views of FIGS. 2 - 3 illustrating the occluding component deployed at base of neck of a targeted, non-spherical outpouching;
- FIG. 4 is a side elevation view similar to the views of FIGS. 2 - 3 illustrating introduction of an embolic agent, for example, a hydrogel, within the outpouching in conjunction with deployment of the retention arms;
- an embolic agent for example, a hydrogel
- FIG. 5 is a side elevation view similar to the views of FIGS. 2 - 4 illustrating an optional positioning balloon coupled to the outer surface of the microcatheter to position the microcatheter relative to the outpouching;
- FIG. 6 is a side plan view illustrating illustrates a detailed deployment of an optional disc balloon
- FIG. 7 is a side elevation view illustrating deployment of multiple independent retention members within the outpouching
- FIG. 8 is a side elevation view illustrating deployment of a single retention arm having a generally linear configuration within an outpouching
- FIG. 9 is a side elevation view illustrating deployment of a single retention arm having a generally coiled configuration within an outpouching filled with hydrogel.
- FIG. 10 is a side elevation view illustrating deployment of a multiple retention arms each having a generally linear configuration within an outpouching filled with hydrogel.
- the present disclosure may be utilized to retain one or more embolic coils introduced within an outpouching, e.g., an aneurysm in a vessel or in a gastro-intestinal organ, to assist in retaining the embolic coils within the outpouching and also provide immediate support within the outpouching potentially minimizing the potential for rupturing of the outpouching or aneurysm.
- the present disclosure provides an occluding device and one or more retention arms which may inter-engage with one or more embolic coils thereby preventing release of the coils though the neck of an outpouching or aneurysm, particularly, large necked aneurysms.
- the mesh occluder may engage any embolic agents such as hydrogel introduced within the outpouching further minimizing the potential of embolic coil migration.
- the present disclosure may be utilized independent of the introduction of embolic coils and/or any other embolic matter or elements.
- the occluding component or mesh may define a more fine or dense mesh material to function as an occluder and, in conjunction with the retention arms, secure the occluder element relative to, and across, the neck as a stand-alone unit.
- the present disclosure will minimize, if not totally eliminate, the necessity of multiple embolic coils, which provides substantial advantages in minimizing aneurysm rupture or other difficulties.
- the present disclosure provides a structure which is immediately stabilized relative to the wall of the outpouching or aneurysm. This immediate stabilization minimizes the potential of displacement of the device, thereby removing potential necessity of closing, repositioning and redeployment of the device minimizing damage to vessels and decreasing operative time.
- the present disclosure employs an occluding component in the form of a mesh element as well as components that secure its position relative to an outpouching before detachment, and before placement of additional embolic materials when needed.
- the present disclosure in illustrative embodiments, provides a self-expandable outpouching filling device that can both cover the neck of an outpouching or aneurysm and serve as a permanent embolic plug in the outpouching, with elements that promptly stabilize its position, with the mesh component in its desired position across the neck of the outpouching, but not projecting into the parent vessel.
- the medical system 1 includes a handle or control element 11 having a housing or frame dimensioned for manipulation by the user, a catheter or microcatheter 12 extending from the handle 12 and a delivery member 13 at least partially extending through the microcatheter 12 and optionally attached to the control element 11 .
- Attached to the delivery member 13 is a mesh occluder 14 .
- the mesh occluder 14 is deployable for ameliorating the outpouching and will be discussed in greater detail hereinbelow.
- the mesh occluder 14 is an occluding component and may or may not be a mesh device. However, for simplicity, the mesh occluder 14 will be referred to hereinafter as a “mesh occluder” for simplicity. However, it is appreciated the occluder may be solid, perforated, contains slits etc.
- the microcatheter 12 may be manipulated via the control element 11 , and may include wires, for example, embedded within the wall of the microcatheter 12 which may be manipulated to navigate the microcatheter through a tortuous vessel, (e.g., a vascular vessel or an intestinal organ).
- the control element 11 may include one or more controls which assist in navigating the microcatheter 12 through the vessel.
- the control element 11 may include circuitry, electronics, etc. capable of sending signals to the microcatheter 12 to manipulate the wires within the microcatheter 12 to laterally move sections of the microcatheter 12 and/or send signals to the delivery member 13 .
- the delivery member 13 may be a solid wire, or in the alternative, a hypotube.
- the delivery member 13 may have a detachment element 17 at its distal end utilized to detachably secure the mesh occluder 14 to the delivery member 13 .
- the control element 11 may send electrical signals, energy, etc. to the detachment element 17 to effect detachment of the mesh occluder 14 .
- the control element 11 may be a stand-alone unit (e.g., commercially available) and coupled to the microcatheter 12 and/or the delivery member 13 prior to performance of the surgical procedure.
- the control element 11 is a permanent component of the medical system 1 . It is envisioned that the medical system 1 may be entirely disposable after a single use or reusable in part or in whole.
- the component of the medical system may be fabricated from materials capable of withstanding conventional sterilization procedures.
- the microcatheter 12 may include one or more exterior mounted balloons to facilitate retention of the microcatheter relative to the vessel and the outpouching.
- the microcatheter 12 may have an outer diameter of 0.5 Fr.-20 Fr. In one embodiment, the microcatheter 12 has an outer diameter ranging from 3 Fr. to 5 Fr.
- FIG. 2 there is illustrated the microcatheter 12 introduced within a vessel 110 and the mesh occluder 14 deployed relative to the target outpouching (e.g., an aneurysm) 100 .
- a contrast agent may be utilized to assist in locating the microcatheter 12 and the mesh occluder 14 relative to the outpouching as is known in the art.
- the deployment of the mesh occluder 14 may be effected through a number of mechanisms.
- the mesh occluder 14 including the mesh occluding component and the retention arms 200 may be disposed within the microcatheter 12 in a compressed state.
- the control unit 11 may be manipulated to advance the delivery member 13 to eject the mesh occluder 14 out the distal end of the microcatheter 12 .
- the mesh occluder 14 assumes a normal expanded state.
- the mesh device of the mesh occluder 14 at least partially extends across the neck of the outpouching 100 and the retention arms 200 deploy within the interior of the outpouching, for example, engaging the interior walls of the outpouching to facilitate retention of the mesh occluder 14 relative to the neck of the outpouching.
- the mesh occluder 14 is a mesh disc, and, may optionally be coated with a hydrogel.
- the terms “mesh occluder” and “mesh disc” are interchangeable.
- an endovascularly deployed mesh (metal mesh or other mesh) disc 14 may optionally have two layers similar to the Anplatz Left Atrial Appendage closure device currently in trials.
- the mesh disc 14 can have versions that are relatively flat, or some versions where the edges are folded up to accommodate differently shaped outpouchings (or aneurysms), including very wide neck outpouchings (or aneurysms).
- Such deviations from the generally flat plane of the mesh occluder or disc 14 of the present disclosure may have turned-up sides which conform to the walls of a target outpouching 100 which are proximal to the neck of the outpouching 100 .
- Such upturned elements 14 A (sometimes referred to as “lips”) ( FIG. 3 A ) are optional and optimally used for very wide neck outpouchings (or aneurysms) that are less spherical in shape and more cylindrical in shape.
- the anatomy does not lend itself to the deployment of a flat mesh disc 14 because wide neck outpouchings (or aneurysms) lack sufficient overhang regions at the neck to support the mesh disc 14 .
- the retention arms 200 form a looped coil matrix with at least portions of the arms 200 engaging the internal wall of the outpouching.
- the retention arms 200 form a dome shape with at least some of the arms connected at one or more locations.
- the retention arms are independent, and can assume any configuration including the dome-shaped matrix shown in FIG. 2 .
- the advantage of the looped coil matrix is that they will provide a structure by which the mesh disc 14 can achieve more immediate and effective stable positioning, by the coil loops gripping the wall of the outpouching, with the mesh portion optimally positioned at the neck of the outpouching.
- the coil loops may be spiral or connected in the form of a birdcage (or dome-shape) or similar structure.
- the prior art teaches essentially spherical or ovoid configurations, and lacks the more effective dome-like shape and dense, somewhat flattened mesh at the bottom (neck of the outpouching) proximal to the distal end of the catheter.
- the properties of the occluding device 14 and the retention members 200 may be controlled whereby the occluding device expands at a faster rate than the retention arms 200 to minimize potential of undesired “dragging” of the retention arms 200 within the walls of the outpouching.
- Other arrangements are also envisioned.
- control unit 11 which is in electrically coupled relation with to the detachment member 17 may relay signals to the occluding component 14 to initiate decompression of the occluding component 14 and at least one retention arm 200 prior to deployment, or cause expansion of the occluding component 14 and the retention arms to its expanded state subsequent to deployment from the microcatheter 12 .
- control element 11 may incorporate mechanical, chemical, hydrostatic, electrical and/or thermal means for implementing the function of deploying the occluding component 14 and the retention arms 200 , and detaching the surgical device 14 from the detachment element 17 .
- the mesh disc 14 and at least one retention arm 200 are deployed through delivery catheter 12 passing through vessel 110 to the base of the neck of target saccular outpouching 100 .
- Control device 11 may optionally signal delivery member 13 to extend beyond the distal end of catheter 12 in a length sufficient to enter target outpouching 100 to allow deployment of mesh disc 14 and at least one retention arm 200 . Once the progress of delivery member ceases, control element 11 signals mesh disc 14 and at least one retention arm 200 to deploy.
- the signal from control element 11 directs the mesh disc 14 and at least one retention arm 200 to open as a blossom to allow the perimeter of the mesh disc 14 and at least one retention arm 200 to overlap the base of the neck of the outpouching 100 .
- the control unit 11 and the microcatheter 12 are manually held in place while the delivery member 13 is manually advanced forward in a length sufficient to enter the target outpouching 100 to allow deployment of the mesh disc 14 and at least one retention arm 200 .
- the mesh disc 14 and at least one retention arm 200 enter the target outpouching in a compacted form and as it is released from its constraint, the mesh disc 14 and at least one retention arm 200 open to allow the perimeter of the disc mesh disc 14 and at least one retention arm 200 to overlap the base of the neck of the outpouching 100 .
- the disc is then gently pulled back manually into position, which is determined preferentially by fluoroscopic and/or angiographic images.
- the upturned elements 14 A are optional and optimally used for very wide neck outpouchings (or aneurysms) that are less spherical in shape and more cylindrical in shape.
- lips 14 A provide sufficient overhang at the neck to support the mesh disc 14 adjacent wide neck outpouchings (or aneurysms).
- the present disclosure contemplates the use of multiple distinct lip configurations.
- the lip configurations differ in diameter, shape and orientation.
- the central portion of the mesh disc i.e. the portion closest to the delivery member, such as the wire or deliver microcatheter
- the central portion of the mesh disc will be oriented parallel to the neck of the target outpouching.
- the diameter of the mesh disc ranges from 0.1 mm to 30 cm.
- the shape of the mesh disc ranges from a circle to triangle. The shape is most typically round or oval.
- the mesh disc 14 may be coated with hydrogel. The interstices of the disc 14 may be dimensioned to contain the hydrogel.
- the entire mesh disc 14 and at least one coil-arm 200 include the lips 14 A and should be oriented parallel to the neck of the target outpouching.
- the lips overhang and rest on the base of the target outpouching, completely covering the neck of the target outpouching and extending over a portion of the adjacent base of the target outpouching and forming a base for at least one retention arm 200 .
- the entire outer perimeter of the mesh disc 14 should be oriented more perpendicular to the neck of the target outpouching than in the case of the typical spherical outpouching with a narrow neck, so as to gently grip the walls near the base of the target outpouching.
- hydrogel 16 can optionally be radio-opaque, which facilitates remote locating and positioning of the hydrogel 16 , this embodiment has been disclosed in prior applications, such as in Application Serial No. in application Ser. No. 16/024,673 to Walzman.
- an alternate embodiment of FIG. 4 further includes a centering balloon 303 within vessel 110 .
- the centering balloon 303 allows catheter element 12 to be positioned more precisely and stably in relation to the center of the neck of target outpouching 100 .
- additional contrast or other fluid injections can optionally be used to initiate deployment of optional balloon(s) 303 or 300 for the purpose of positioning catheter 12 so as to center delivery microcatheter 13 for optimal deployment of mesh disc 14 .
- the balloon is described in detail in Walzman application Ser. No. 14/482,436 (entitled Vessel access catheter), incorporated herewith by reference.
- the centering balloon 303 may be either a single balloon or a balloon array.
- the single balloon or balloon arrays are designed to assist in centering the tip of catheter element 12 to a location proximal to the center of the target outpouching.
- the positioning may be achieved by the inflation of at least one balloon in order to deflect catheter element 12 in a desired direction.
- An additional embodiment of the current disclosure incorporates the Walzman disc balloon 300 , as illustrated by FIG. 6 , into catheter element 12 .
- the incorporation is an alternate embodiment which is designed to help center the tip of catheter element 12 to a location proximal to the center of the target outpouching. It may also act as vertical positioning element by abutting the base of the mesh disc during positioning in the target outpouching.
- Both balloon embodiments separately or in combination are also designed to arrest flow within the vessel proximate to the target outpouching when fully inflated.
- the inflation will result in control of unwanted bleeding in case of target outpouching rupture.
- the present disclosure can have several different embodiments, including:
- a disc alone an appropriately sized disc—can be deployed through a microcatheter in a saccular aneurysm, after a second microcatheter is placed in the microcatheter.
- the disc is gently pulled back to the neck of the outpouching, bridging the neck, and with a lip beyond the open portion of the neck to stabilize the disc.
- the disc is not detached at first, but remains tethered to its delivery element 13 (a wire or catheter). Were it to be deployed early it would likely migrate into the outpouching and be ineffective.
- embolic coils are sequentially placed and deployed into the outpouching per current routine protocols/techniques, until the outpouching is adequately filled with embolic coils.
- the second microcatheter is removed. At this point the disc is detached from its delivery wire/catheter, which is removed.
- a disc mounted on a hypotube or delivery member 13 is introduced into the outpouching through a slightly larger catheter, wherein the hypotube or delivery member 13 goes through the disc to extend just beyond it.
- An appropriately sized disc can be deployed through a microcatheter in a saccular aneurysm.
- the disc 14 is gently pulled back to the neck of the outpouching, bridging the neck, and with a lip 14 A beyond the open portion of the neck to stabilize the disc 14 .
- the disc 14 is not detached at first but remains tethered to its delivery member/hypotube 13 . Were it to be detached early, it would likely migrate into the outpouching and be ineffective.
- the disc 14 is an endovascularly deployed mesh composed of a shape-memory material such as nickel-titanium alloy or other memory-shape material capable of super-elastic properties, such that the compressed mesh disc 14 will revert to its flat-mesh disc shape upon release or activation by an electronic or light impulse. It will optionally have two layers similar to the Anplatz Left Atrial Appendage closure device currently in trials—the disc can have versions that are relatively flat, or some versions where the edges are folded up to accommodate different shape outpouchings (or aneurysms), including very wide neck outpouching.
- a shape-memory material such as nickel-titanium alloy or other memory-shape material capable of super-elastic properties
- the outside surface of the disc facing into the outpouching is lined with a non-biodegradable hydrogel, that when exposed to blood upon deployment, will swell over a prescribed time (10 minutes in the preferred embodiment of the present disclosure), to conform to the size and shape of the outpouching, and fill and occlude the outpouching.
- the other layer of the disc 14 that is closer to the parent artery can optionally have thin layers of hydrogel as well—but this layer would have hydrogel designed only to swell to occlude that layer of disc alone, so no hydrogel from the other layer can potentially expand through the mesh into the parent vessel.
- An appropriately sized disc 14 can be deployed through a microcatheter in a saccular aneurysm.
- the disc is gently pulled back to the neck of the aneurysm, bridging the neck, and with a lip beyond the open portion of the neck to stabilize the disc.
- the disc is not detached at first but remains tethered to its delivery system (a wire or catheter). Were it to be detached early it would likely migrate into the outpouching and be ineffective.
- the disc is held in place at the neck of the outpouching, while the hydrogels swell.
- the disc is detached from its delivery wire/catheter, and the delivery wire/catheter and the microcatheter through which it was deployed are removed.
- hydrogel may be used in filling the outpouching, which occludes that outpouching and also stabilizes the disc in place (in example 1 and 2 above the coils achieve these 2 goals).
- the disc can have a smaller metal core disc 14 B ( FIG. 2 ) dimensioned smaller than the diameter of the outpouching and having hydrogel designed to expand out in a disc like shape from the edges, to make a larger disc that can then be gently dragged into position. It can then be pinned in place by coils or optional hydrogel embedded in the top of the disc, that also then expands into the dome of the outpouching, either via a layer on the top of the metal disc designed to expand after the side hydrogel, or via a separately implanted hydrogel bead or the like.
- a smaller disc can also be used in combination with other embolic fillers, wherein the disc is secured by the at least one arm extension, and the disc serves to reduce the effective width of the neck of the outpouching.
- the mesh disc 14 and at least one retention arm 200 may also optionally be delivered through a disc balloon microcatheter (previously described by Walzman Ser. No. 14/732,170) or a similar configuration (disc balloon), an intermediate catheter, or another balloon catheter. These can serve as methods for delivering the occluding component of the present disclosure.
- the method(s) may also be used to deliver any mesh intrasaccular device including other devices taught by the prior art, such as the Web and the Luna.
- the balloon may sometimes be helpful in positioning the mesh disc 14 and at least one retention coil-arm 200 , and second, that in the event the outpouching ruptures during treatment, the balloon can be inflated to arrest flow and control active bleeding until more coils can be placed.
- the disc and the retentions arms 200 as coil loops vary in size and in the time necessary to fully deploy. More particularly, the diameter of the discs varies from 0.1 mm-500 mm. The diameter of the coil loops varies from 0.1 mm-1000 mm. The length of the coil loops can be 0.1 mm-3142 mm long. Coil loops for coil disclosure are typically sized in diameter of the target outpouching.
- both the disc 14 and the retention arm 200 or coil expand at the same rate, in other embodiments the disc and the coil expand at independent rates. In some embodiments the coil expands faster than the disc and in other embodiments the disc expands faster than the coil.
- the retention arms 200 or coils complete their expansion approximately forty-five (45) seconds after the disc completes its expansion.
- This time off set allows the occluding component to be positioned into optimal position across neck (the opening) of the target outpouching without dragging metal under outward tension along the target outpouching or vessel walls thus eliminating or ameliorating medical difficulties such as breaching the outpouching or the vessel walls.
- the breaches can result in injury or death to a patient.
- the present disclosure has at least four structural optional elements.
- the optional element are central donut holes in the disc element of the present disclosure; single or multiple mesh layer(s) in the disc element of the present disclosure; hydrogel coating on all or parts of the disc element of the present disclosure; and hydrogel coating of all or parts of the retention arm element(s) of the present disclosure.
- the donut hole structure in the disc element of the present disclosure is optional.
- One embodiment of the present disclosure has a central donut hole structure.
- Another embodiment of the present disclosure does not have a central donut hole structure.
- the single layered mesh configuration of the present configuration is optional.
- One embodiment of the present disclosure has a single mesh layer in the disc element of the present disclosure.
- Another embodiment of the present disclosure the present disclosure has multiple mesh layers in the disc element of the present disclosure.
- a hydrogel coating of the disc element of the present disclosure is optional.
- One embodiment of the present disclosure discloses a hydrogel coating on the surfaces of the disc element 14 of the present disclosure.
- the hydrogel coating is not applied to the surfaces of the disc element 14 .
- a hydrogel coating is employed on some but not all surfaces of the mesh disc 14 .
- the hydrogel is chemically optimized to expand significantly, and may also be positioned so that it expands, into the pathological outpouching, to further aid in the thrombosis/closure of the aneurysm/outpouching.
- a hydrogel coating of the retention arm element(s) 200 of the present disclosure is optional.
- One embodiment of the present disclosure discloses a hydrogel coating on the surfaces of the retention arm element(s) 200 .
- the hydrogel coating is not applied to some of the surfaces of the retention arm element(s) 200 .
- the hydrogel coating is not applied to any of the surfaces of the retention arm element(s) 200 .
- At least one or more retention arms 200 in the shape of a coil are attached to the mesh component and extend within the outpouching.
- the retention arms 200 may engage the internal wall of the outpouching and/or the embolic coil 24 to assist in retention of the embolic coil 24 and the mesh disc or occluder 14 relative to the neck of the outpouching wall.
- FIG. 8 illustrates an embodiment utilizing a substantially linear retention arm 200 which may be advantageous is small outpouchings or outpouchings having atypical shape.
- the ends of the linear retention arms 200 may be blunt to avoid any potential undesired engagement with the wall of the outpouching.
- the embolic coil 24 is delivered through the microcatheter 12 .
- Illustrative embodiments utilize multiple coiled retention arms attached to the mesh occluder 14 (e.g., as depicted in FIG. 7 ).
- the retention arms 200 and the mesh occluder may function as a stand-alone flow diverter.
- Various configurations of the retention arms 200 are contemplated.
- the delivery member may further comprise a channel capable of delivering at least one coil therethrough.
- At least one additional coil may be serially delivered through the delivery member.
- a matrix of the serially delivered coils are adapted to form shapes of suitable geometry potentially fill the outpouching.
- the mesh disc 14 may be configured to be impregnated with adhered hydrogel in a sufficient amount to wedge the mesh disc into a target vascular structure.
- the adhered hydrogel may be radio-opaque.
- an embolic device for ameliorating an outpouching comprises a control element, a catheter element, a wire, a detachment element, a mesh disc, at least one arm extension adhered to the mesh disc, and a distal opening, wherein the mesh disc further comprises a proximal face and a distal face, the proximal face being opposite of the distal face; and the proximal face and the distal faces are substantially flat; wherein the mesh disc further comprises peripheral lips, and a disc core having a diameter configured to be smaller than the aneurysm, and wherein the mesh disc is secured in place by the at least one arm extension.
- the mesh disc with the at least one arm extension comprises a matrix adapted to form shapes of suitable geometry for conforming to the contours of the outpouching.
- the matrix may be configured to substantially fill the aneurysm.
- the mesh disc and the at least one extension or retention arm may be configured to be impregnated with adhered hydrogel in a sufficient amount to wedge the mesh disc into a target vascular structure.
- the mesh disc may be configured to be positioned at the neck of the outpouching.
- the mesh disc may be configured not to substantially fill the outpouching.
- the mesh disc may further comprise at least one additional layer.
- the at least one additional layer may further include the adhered hydrogel adapted to alter flow through only the one additional layer.
- the mesh disc with the at least one extension arm may be adapted to grip the walls of the outpouching, and configured to stabilize the mesh disc in position at the neck of the outpouching.
- the device may comprise a delivery member having a channel capable of delivering at least one coil therethrough.
- At least one additional coil is serially delivered through the channel of the delivery member.
- At least one additional coil is serially delivered comprise a matrix adapted to form shapes of suitable geometry to fill an outpouching.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Neurosurgery (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Surgical Instruments (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
Abstract
Description
Claims (46)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/020,797 US12426885B2 (en) | 2016-12-05 | 2020-09-14 | Mesh cap for ameliorating outpouchings |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662497851P | 2016-12-05 | 2016-12-05 | |
| US201762600134P | 2017-02-13 | 2017-02-13 | |
| US15/732,519 US10543015B2 (en) | 2016-12-05 | 2017-11-20 | Mesh disc for saccular aneurysms and cover for saccular out-pouching |
| US16/024,639 US10617428B2 (en) | 2016-12-05 | 2018-06-29 | Complex coil with mesh cap |
| US16/602,319 US11382636B2 (en) | 2016-12-05 | 2019-09-12 | Mesh cap for ameliorating outpouchings |
| US17/020,797 US12426885B2 (en) | 2016-12-05 | 2020-09-14 | Mesh cap for ameliorating outpouchings |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US16/602,319 Continuation-In-Part US11382636B2 (en) | 2016-12-05 | 2019-09-12 | Mesh cap for ameliorating outpouchings |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20200405347A1 US20200405347A1 (en) | 2020-12-31 |
| US12426885B2 true US12426885B2 (en) | 2025-09-30 |
Family
ID=74043354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/020,797 Active 2039-12-16 US12426885B2 (en) | 2016-12-05 | 2020-09-14 | Mesh cap for ameliorating outpouchings |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US12426885B2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11583289B2 (en) | 2008-05-01 | 2023-02-21 | Aneuclose Llc | Aneurysm-occluding mesh ribbon with a series of loops or segments having distal-to-proximal variation in size, shape, and/or orientation |
| US11471164B2 (en) | 2008-05-01 | 2022-10-18 | Aneuclose Llc | Methods of occluding a cerebral aneurysm by inserting embolic members or material into an intrasacular implant |
| US11357511B2 (en) | 2008-05-01 | 2022-06-14 | Aneuclose Llc | Intrasacular aneurysm occlusion device with globular first configuration and bowl-shaped second configuration |
| US12004750B2 (en) | 2008-05-01 | 2024-06-11 | Aneuclose Llc | Methods for creating an expandable two-part intrasacular aneurysm occlusion device from a tubular mesh |
| WO2015166013A1 (en) | 2014-04-30 | 2015-11-05 | Cerus Endovascular Limited | Occlusion device |
| EP3386402B1 (en) | 2015-12-07 | 2022-02-23 | Cerus Endovascular Limited | Occlusion device |
| US10869672B2 (en) | 2016-03-11 | 2020-12-22 | Cents Endovascular Limited | Occlusion device |
| JP7414710B2 (en) | 2017-08-21 | 2024-01-16 | シーラス エンドバスキュラー リミテッド | occlusion device |
| US11406404B2 (en) | 2020-02-20 | 2022-08-09 | Cerus Endovascular Limited | Clot removal distal protection methods |
Citations (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3874388A (en) | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
| US4282875A (en) | 1979-01-24 | 1981-08-11 | Serbinenko Fedor A | Occlusive device |
| US4346712A (en) | 1979-04-06 | 1982-08-31 | Kuraray Company, Ltd. | Releasable balloon catheter |
| US4619246A (en) | 1984-05-23 | 1986-10-28 | William Cook, Europe A/S | Collapsible filter basket |
| US4675361A (en) | 1980-02-29 | 1987-06-23 | Thoratec Laboratories Corp. | Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming |
| US4921478A (en) | 1988-02-23 | 1990-05-01 | C. R. Bard, Inc. | Cerebral balloon angioplasty system |
| US5165421A (en) | 1987-09-30 | 1992-11-24 | Lake Region Manufacturing Co., Inc. | Hollow lumen cable apparatus |
| US5263963A (en) | 1989-09-08 | 1993-11-23 | Advanced Cardiovascular Systems, Inc. | Expandable cage catheter for repairing a damaged blood vessel |
| US5334210A (en) | 1993-04-09 | 1994-08-02 | Cook Incorporated | Vascular occlusion assembly |
| US5628761A (en) | 1994-07-08 | 1997-05-13 | Rizik; David G. | Guide wire passage creation device |
| US5733294A (en) | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
| US5907893A (en) | 1996-01-30 | 1999-06-01 | Medtronic, Inc. | Methods for the manufacture of radially expansible stents |
| US6221086B1 (en) | 1998-03-13 | 2001-04-24 | B. Braun Medical Sas | Covered self-expanding vascular occlusion device |
| US6375670B1 (en) | 1999-10-07 | 2002-04-23 | Prodesco, Inc. | Intraluminal filter |
| US20020173835A1 (en) | 1999-06-04 | 2002-11-21 | Advanced Stent Technologies, Llc | Short sleeve stent delivery catheter and methods |
| US6605102B1 (en) | 1994-07-08 | 2003-08-12 | Ev3, Inc. | Intravascular trap and method of trapping particles in bodily fluids |
| US20040087998A1 (en) * | 2002-08-29 | 2004-05-06 | Scimed Life Systems, Inc. | Device and method for treatment of a vascular defect |
| US20040127935A1 (en) * | 1999-10-27 | 2004-07-01 | Atritech, Inc. | Filter apparatus for ostium of left atrial appendage |
| US20050159645A1 (en) | 2003-11-12 | 2005-07-21 | Bertolero Arthur A. | Balloon catheter sheath |
| US20060106421A1 (en) * | 2004-11-16 | 2006-05-18 | Clifford Teoh | Expansible neck bridge |
| US7128736B1 (en) * | 1998-09-04 | 2006-10-31 | Boston Scientific Scimed, Inc. | Detachable aneurysm neck closure patch |
| US20060293612A1 (en) | 2004-06-24 | 2006-12-28 | Boston Scientific Scimed, Inc. | Apparatus and method for treating occluded vasculature |
| US20070078480A1 (en) | 2005-10-04 | 2007-04-05 | Boston Scientific Scimed, Inc. | Self-expanding biodegradable or water-soluble vaso-occlusive devices |
| US20080033341A1 (en) | 2006-08-04 | 2008-02-07 | Bay Holdings Ltd. | Methods and devices for reducing or blocking blood flow to a selected blood vessel or part thereof |
| US7575582B2 (en) | 2000-02-09 | 2009-08-18 | Micrus Corporation | Apparatus for deployment of micro-coil using a catheter |
| US20100069948A1 (en) | 2008-09-12 | 2010-03-18 | Micrus Endovascular Corporation | Self-expandable aneurysm filling device, system and method of placement |
| WO2011057002A2 (en) | 2009-11-05 | 2011-05-12 | Sequent Medical Inc. | Multiple layer filamentary devices or treatment of vascular defects |
| US20110144669A1 (en) | 2007-09-11 | 2011-06-16 | Nfocus Neuromedical Inc. | Aneurysm cover device for embolic delivery and retention |
| US20130045182A1 (en) | 2009-11-09 | 2013-02-21 | Glen Gong | Polysaccharide Based Hydrogels |
| US20150272589A1 (en) * | 2014-03-31 | 2015-10-01 | DePuy Synthes Products, LLC | Aneurysm occlusion device |
| US20160022445A1 (en) * | 2013-03-15 | 2016-01-28 | Covidien Lp | Occlusive Device |
| US20190209178A1 (en) * | 2016-09-14 | 2019-07-11 | Medinol Ltd. | Aneurysm closure device |
| US20200046370A1 (en) * | 2018-08-08 | 2020-02-13 | DePuy Synthes Products, Inc. | Delivery system for embolic braid |
-
2020
- 2020-09-14 US US17/020,797 patent/US12426885B2/en active Active
Patent Citations (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3874388A (en) | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
| US4402319A (en) | 1977-09-14 | 1983-09-06 | Kuraray Co., Ltd. | Releasable balloon catheter |
| US4282875A (en) | 1979-01-24 | 1981-08-11 | Serbinenko Fedor A | Occlusive device |
| US4346712A (en) | 1979-04-06 | 1982-08-31 | Kuraray Company, Ltd. | Releasable balloon catheter |
| US4675361A (en) | 1980-02-29 | 1987-06-23 | Thoratec Laboratories Corp. | Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming |
| US4619246A (en) | 1984-05-23 | 1986-10-28 | William Cook, Europe A/S | Collapsible filter basket |
| US5165421A (en) | 1987-09-30 | 1992-11-24 | Lake Region Manufacturing Co., Inc. | Hollow lumen cable apparatus |
| US4921478A (en) | 1988-02-23 | 1990-05-01 | C. R. Bard, Inc. | Cerebral balloon angioplasty system |
| US5263963A (en) | 1989-09-08 | 1993-11-23 | Advanced Cardiovascular Systems, Inc. | Expandable cage catheter for repairing a damaged blood vessel |
| US5334210A (en) | 1993-04-09 | 1994-08-02 | Cook Incorporated | Vascular occlusion assembly |
| US5628761A (en) | 1994-07-08 | 1997-05-13 | Rizik; David G. | Guide wire passage creation device |
| US6605102B1 (en) | 1994-07-08 | 2003-08-12 | Ev3, Inc. | Intravascular trap and method of trapping particles in bodily fluids |
| US5907893A (en) | 1996-01-30 | 1999-06-01 | Medtronic, Inc. | Methods for the manufacture of radially expansible stents |
| US5733294A (en) | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
| US6221086B1 (en) | 1998-03-13 | 2001-04-24 | B. Braun Medical Sas | Covered self-expanding vascular occlusion device |
| US7128736B1 (en) * | 1998-09-04 | 2006-10-31 | Boston Scientific Scimed, Inc. | Detachable aneurysm neck closure patch |
| US20020173835A1 (en) | 1999-06-04 | 2002-11-21 | Advanced Stent Technologies, Llc | Short sleeve stent delivery catheter and methods |
| US6375670B1 (en) | 1999-10-07 | 2002-04-23 | Prodesco, Inc. | Intraluminal filter |
| US20040127935A1 (en) * | 1999-10-27 | 2004-07-01 | Atritech, Inc. | Filter apparatus for ostium of left atrial appendage |
| US7575582B2 (en) | 2000-02-09 | 2009-08-18 | Micrus Corporation | Apparatus for deployment of micro-coil using a catheter |
| US20040087998A1 (en) * | 2002-08-29 | 2004-05-06 | Scimed Life Systems, Inc. | Device and method for treatment of a vascular defect |
| US20050159645A1 (en) | 2003-11-12 | 2005-07-21 | Bertolero Arthur A. | Balloon catheter sheath |
| US20100087709A1 (en) | 2003-11-12 | 2010-04-08 | Bertolero Arthur A | Balloon catheter sheath |
| US20060293612A1 (en) | 2004-06-24 | 2006-12-28 | Boston Scientific Scimed, Inc. | Apparatus and method for treating occluded vasculature |
| US20060106421A1 (en) * | 2004-11-16 | 2006-05-18 | Clifford Teoh | Expansible neck bridge |
| US20070078480A1 (en) | 2005-10-04 | 2007-04-05 | Boston Scientific Scimed, Inc. | Self-expanding biodegradable or water-soluble vaso-occlusive devices |
| US20080033341A1 (en) | 2006-08-04 | 2008-02-07 | Bay Holdings Ltd. | Methods and devices for reducing or blocking blood flow to a selected blood vessel or part thereof |
| US20110144669A1 (en) | 2007-09-11 | 2011-06-16 | Nfocus Neuromedical Inc. | Aneurysm cover device for embolic delivery and retention |
| US20100069948A1 (en) | 2008-09-12 | 2010-03-18 | Micrus Endovascular Corporation | Self-expandable aneurysm filling device, system and method of placement |
| WO2011057002A2 (en) | 2009-11-05 | 2011-05-12 | Sequent Medical Inc. | Multiple layer filamentary devices or treatment of vascular defects |
| US20110152993A1 (en) | 2009-11-05 | 2011-06-23 | Sequent Medical Inc. | Multiple layer filamentary devices or treatment of vascular defects |
| US20130045182A1 (en) | 2009-11-09 | 2013-02-21 | Glen Gong | Polysaccharide Based Hydrogels |
| US20160022445A1 (en) * | 2013-03-15 | 2016-01-28 | Covidien Lp | Occlusive Device |
| US20150272589A1 (en) * | 2014-03-31 | 2015-10-01 | DePuy Synthes Products, LLC | Aneurysm occlusion device |
| US20190209178A1 (en) * | 2016-09-14 | 2019-07-11 | Medinol Ltd. | Aneurysm closure device |
| US20200046370A1 (en) * | 2018-08-08 | 2020-02-13 | DePuy Synthes Products, Inc. | Delivery system for embolic braid |
Also Published As
| Publication number | Publication date |
|---|---|
| US20200405347A1 (en) | 2020-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12426885B2 (en) | Mesh cap for ameliorating outpouchings | |
| US11382636B2 (en) | Mesh cap for ameliorating outpouchings | |
| JP7338826B2 (en) | vascular occluder | |
| US20240050096A1 (en) | Vascular Occlusion | |
| US10543015B2 (en) | Mesh disc for saccular aneurysms and cover for saccular out-pouching | |
| EP4027943A1 (en) | Mesh cap for ameliorating outpouchings | |
| US11730485B2 (en) | Devices, systems, and methods for the treatment of vascular defects | |
| US8425548B2 (en) | Occluding member expansion and then stent expansion for aneurysm treatment | |
| CA2481224C (en) | Devices for retaining vaso-occlussive devices within an aneurysm | |
| EP2707077B1 (en) | Device for occluding a lumen | |
| US20190216467A1 (en) | Apparatus and Methods for Intravascular Treatment of Aneurysms | |
| US20100168781A1 (en) | Expandable body cavity liner device | |
| BR102019018819A2 (en) | IMPROVED ANEURISM OCCLUSION DEVICE | |
| JP2017515567A (en) | Intracranial stent and embolic coil coated with photon activated gel | |
| CA2298637A1 (en) | Occlusion system for aneurysm repair | |
| EP3773251A1 (en) | Embolization scaffold devices | |
| US20230190292A1 (en) | Occlusive devices with petal-shaped regions for treating vascular defects |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
| FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |